SkylineDx
Business Services · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Lichtenauerlaan Brainpark Ii Building Xi...Phone Number
+31 107200310Website
www.skylinedx.comRevenue
$5.9 MillionIndustry
About SkylineDx
SkylineDx Org Chart
Is SkylineDx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at SkylineDx
Product Launch: Get notified when SkylineDx launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
SkylineDx, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once SkylineDx has new funding data
Website visits: Recent activity has been detected on your website
Check out if SkylineDx is spiking on competitors!
Earning: See what the market has to say on SkylineDx recently announced quarterly report
Click to see if SkylineDx had a recent Job posting/layoffs
Check if SkylineDx has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined SkylineDx as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
SkylineDx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SkylineDx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SkylineDx.
SkylineDx Tech Stack
A closer look at the technologies used by SkylineDx
Most Recent Scoops
SkylineDx News & Media
SkylineDx to Showcase New Cutaneous Squamous Cell Carcinoma Findings at 83rd Society for Investigative Dermatology Annual Meeting
An international consortium of leading cancer centers and SkylineDx has put together a comprehensive data resource to characterize the genomic and transcriptomic landscape of cutaneous squamous cell carcinoma (CSCC) and its association with metastatic risk and survival. A novel...SkylineDx to Present Data on Precision Molecular Diagnostics Advances in Cutaneous Squamous Cell Carcinoma at 22nd EADO Congress
New gene-signature for cutaneous squamous cell carcinoma (CSCC) demonstrates ability to identify a subset of patients with higher risk of developing metastasis, outperforming existing staging systems ROTTERDAM, Netherlands and SAN DIEGO, April 23, 2026 /PRNewswire/ -- SkylineDx, an...Merlin CP-GEP™ Demonstrates Superior Predictive Accuracy for Sentinel Lymph Node Metastasis in Early-Stage Melanoma
Peer-reviewed publication confirms Merlin CP-GEP¹ identifies a subset of T1a patients with SLN positivity above guideline thresholds Two Independent validations at Leading Academic Centers reported no high-risk T1a classifications in an Alternative GEP test SAN DIEGO and ROTTERDAM,...SkylineDx Launches a Guideline-Informed Risk Assessment Initiative to Support SLNB Decision-Making in Early-Stage Melanoma
The Initiative helps clinicians align their clinical practice with updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Melanoma (Version 1.2026) framework Provides T1b and T2a melanoma patients with a PREDICTIVE molecular test to assess individualized SLN metastasis...
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SkylineDx
Founded in 2005 and headquartered in The Netherlands, SkylineDx is a biotechnology company, focused on research and development of molecular diagnostics in oncology and inflammatory diseases.... Read More